StockData
Annexon, Inc. logo

Annexon, Inc. (ANNX) stock

ANNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$3.47−0.10 (-2.80%)

Close on Nov 17, 2026Market cap $709.42MP/E –Yield 0.00%

Annexon operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Annexon's operating cash flow for the twelve months ending Jun 30, 2026 was -$193.03M. For fiscal 2025 it was -$186.36M. The highest annual figure on record is -$28.36M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$186.36M–
FY2024Dec 31, 2024-$118.01M–
FY2023Dec 31, 2023-$121.14M–
FY2022Dec 31, 2022-$116.31M–
FY2021Dec 31, 2021-$106.11M–
FY2020Dec 31, 2020-$53.09M–
FY2019Dec 31, 2019-$28.36M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$48.01M–
Q1 FY2026Mar 31, 2026-$46.80M–
Q4 FY2025Dec 31, 2025-$45.93M–
Q3 FY2025Sep 30, 2025-$52.30M–
Q2 FY2025Jun 30, 2025-$38.07M–
Q1 FY2025Mar 31, 2025-$50.06M–
Q4 FY2024Dec 31, 2024-$36.02M–
Q3 FY2024Sep 30, 2024-$32.02M–
Q2 FY2024Jun 30, 2024-$21.71M–
Q1 FY2024Mar 31, 2024-$28.27M–
Q4 FY2023Dec 31, 2023-$23.48M–
Q3 FY2023Sep 30, 2023-$28.29M–
Q2 FY2023Jun 30, 2023-$36.38M–
Q1 FY2023Mar 31, 2023-$32.99M–
Q4 FY2022Dec 31, 2022-$27.14M–
Q3 FY2022Sep 30, 2022-$30.72M–
Q2 FY2022Jun 30, 2022-$28.16M–
Q1 FY2022Mar 31, 2022-$30.29M–
Q4 FY2021Dec 31, 2021-$28.32M–
Q3 FY2021Sep 30, 2021-$29.72M–
Q2 FY2021Jun 30, 2021-$24.63M–
Q1 FY2021Mar 31, 2021-$23.44M–
Q4 FY2020Dec 31, 2020-$19.26M–
Q3 FY2020Sep 30, 2020-$13.58M–
Q2 FY2020Jun 30, 2020-$10.25M–
Q1 FY2020Mar 31, 2020-$10.00M–
Q4 FY2019Dec 31, 2019-$8.79M–
Q3 FY2019Sep 30, 2019-$6.87M–

More Annexon figures

See a number that looks wrong?